Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jul 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$47K
Net Open-Market Flow
-$47K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 16, 2024Sell(S)2K$27.11$47K7K
Jul 16, 2024Option exercise(M)1K$8.04$10K9K
Jul 16, 2024Option exercise(M)500$6.49$3K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 16, 2024Option exercise(M)1K—$033K
Jul 16, 2024Option exercise(M)500—$011K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-084725) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML